Risk-adapted approach for fever and neutropenia in paediatric cancer patients - A national multicentre study

European Journal of Cancer

Volumn 53, Issue , 2016, Pages 16-24

  Miedema, Karin G E ^a   Tissing, Wim J E ^a   Abbink, Floor C H ^b   Ball, Lynne M ^c   Michiels, Erna M C ^d   Van Vliet, Michel J ^a   De Vries, Wilma Y ^a   Kamps, Willem A ^a   Norbruis, Obbe F ^e   Fiocco, Marta ^f,g   De Groot Kruseman, Hester A ^f   Van De Wetering, Marianne D ^h   De Bont, Eveline S J M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e Isala Klinieken ^*  (Netherlands)

^f Dutch Childhood Oncology Group (SKION)   (Netherlands)

^g LEIDEN UNIVERSITY   (Netherlands)

^h EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Antibiotics; Children; Fever; IL 8; Neutropenia; Risk assessment model

Indexed keywords

ANTIBIOTIC AGENT; INTERLEUKIN 8; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ABSENCE OF SIDE EFFECTS; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BRAIN TUMOR; CANCER PATIENT; CHILD; CHILDHOOD CANCER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFANT; LOW RISK PATIENT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL COUNT; NEWBORN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT FEVER; RISK ASSESSMENT; SOLID TUMOR; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; AMBULATORY CARE; BACTEREMIA; CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA; CLINICAL TRIAL; DRUG ADMINISTRATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; NEOPLASMS; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTEREMIA; CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84949575476     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.10.065     Document Type: Article

References (43)

1. W.T. Hughes, D. Armstrong, G.P. Bodey, E.J. Bow, A.E. Brown, T. Calandra, and et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 1537-6591; 6 2002 03/15 730 751
2. I. Hann, C. Viscoli, M. Paesmans, H. Gaya, and M. Glauser A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) Br J Haematol 99 0007-1048; 3 1997 12 580 588
3. R.A. Ammann, A. Hirt, A.R. Luthy, and C. Aebi Predicting bacteremia in children with fever and chemotherapy-induced neutropenia Pediatr Infect Dis J 23 1 2004 Jan 61 67
4. E. Speyer, A. Herbinet, A. Vuillemin, P. Chastagner, and S. Briancon Agreement between children with cancer and their parents in reporting the child's health-related quality of life during a stay at the hospital and at home Child Care Health Dev 35 4 2009 Jul 489 495
5. O. Teuffel, E. Amir, S.M. Alibhai, J. Beyene, and L. Sung Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer Pediatrics 127 2 2011 Feb e279 e286
6. H.A. El-Mahallawy, M. El-Wakil, M.M. Moneer, and L. Shalaby Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer Pediatr Blood Cancer 57 2 2011 Aug 283 288
7. M. Kamboj, and K.A. Sepkowitz Nosocomial infections in patients with cancer Lancet Oncol 10 6 2009 Jun 589 597
8. C. Oude Nijhuis, W.A. Kamps, S.M. Daenen, J.A. Gietema, W.T. van der Graaf, H.J. Groen, and et al. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients J Clin Oncol 23 0732-183; 30 2005 10/20 7437 7444
9. N. Mukaida Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation Int J Hematol 72 0925-5710; 4 2000 12 391 398
10. G.R. Stryjewski, E.S. Nylen, M.J. Bell, R.H. Snider, K.L. Becker, A. Wu, and et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children Pediatr Crit Care Med 6 1529-7535; 2 2005 03 129 135
11. A. Lindemann, I. Tamm, K. Tanodi, and R. Mertelsmann Interleukin-8 serum levels for early detection of infectious episodes in neutropenic patients J Infect Dis 172 0022-1899; 2 1995 08 610
12. E.L. Mueller, K.J. Walkovich, G.A. Yanik, and S.J. Clark Variation in management of fever and neutropenia among pediatric patients with cancer: a survey of providers in Michigan Pediatr Hematol Oncol 32 5 2015 Aug 331 340
13. K.G. Miedema, E.S. de Bont, R.F. Elferink, M.J. van Vliet, C.S. Nijhuis, W.A. Kamps, and et al. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia Support Care Cancer 19 10 2011 Oct 1593 1600
14. R. Newcombe Two-sided confidence intervals for the single proportion: comparison of seven methods Stat Med 17 1998 857 872
15. D. Altman Practical statistics for medical research 1999 Chapman & Hall London
16. K.Y.Z.S. Liang Longitudinal data analysis using generalized linear models Biometrica 73 1 1986 13 22
17. R.A. Ammann, A. Hirt, A.R. Luthy, and C. Aebi Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection Med Pediatr Oncol 41 0098-1532; 5 2003 11 436 443
18. M.E. Santolaya, A.M. Alvarez, A. Becker, J. Cofre, N. Enriquez, M. O'Ryan, and et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever J Clin Oncol 19 0732-183; 14 2001 07/15 3415 3421
19. M.E. Santolaya, A.M. Alvarez, C.L. Aviles, A. Becker, A. King, C. Mosso, and et al. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial Pediatr Infect Dis J 27 6 2008 Jun 538 543
20. H.R. Paganini, C. Aguirre, G. Puppa, C. Garbini, R.G. Javier, G. Ensinck, and et al. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer Cancer 109 12 2007 Jun 15 2572 2579
21. S. Wicki, A. Keisker, C. Aebi, K. Leibundgut, A. Hirt, and R.A. Ammann Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy? Pediatr Blood Cancer 51 6 2008 Dec 778 783
22. M.E. Santolaya, A.M. Alvarez, C.L. Aviles, A. Becker, J. Cofre, N. Enriquez, and et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia Clin Infect Dis 35 1537-6591; 1058-4838; 6 2002 09/15 678 683
23. R.A. Ammann, N. Bodmer, A. Hirt, F.K. Niggli, D. Nadal, A. Simon, and et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study J Clin Oncol 2010 03/15 (1527-7755; 0732-183)
24. P.I. Rondinelli, C. Ribeiro Kde, and B. de Camargo A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia J Pediatr Hematol Oncol 28 10 2006 Oct 665 670
25. E.M. te Poele, W.J. Tissing, W.A. Kamps, and E.S. de Bont Risk assessment in fever and neutropenia in children with cancer: What did we learn? Crit Rev Oncol Hematol 72 1879-0461; 1879-0461; 1 2009 10 45 55
26. A. Gupta, C. Swaroop, S. Agarwala, R.M. Pandey, and S. Bakhshi Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia J Pediatr Hematol Oncol 31 9 2009 Sep 635 641
27. A. Petrilli, F. Altruda Carlesse, and C. Alberto Pires Pereira Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia Pediatr Blood Cancer 49 5 2007 Oct 15 682 686
28. A.R. Cagol, C.G. Castro Junior, M.C. Martins, A.L. Machado, R.C. Ribeiro, L.J. Gregianin, and et al. Oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy J Pediatr (Rio J) 85 6 2009 Nov-Dec 531 535
29. R. Dommett, J. Geary, S. Freeman, J. Hartley, M. Sharland, A. Davidson, and et al. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting Eur J Cancer 45 16 2009 Nov 2843 2849
30. L.M. Orme, F.E. Babl, C. Barnes, P. Barnett, S. Donath, and D.M. Ashley Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial Pediatr Blood Cancer 61 8 2014 Aug 1427 1433
31. F. Gibson, J. Chisholm, E. Blandford, P. Donachie, J. Hartley, S. Lane, and et al. Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care Support Care Cancer 21 5 2013 May 1241 1251
32. A. Manji, J. Beyene, L.L. Dupuis, R. Phillips, T. Lehrnbecher, and L. Sung Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children-a systematic review of prospective trials Support Care Cancer 20 6 2012 Jun 1135 1145
33. T. Lehrnbecher, R. Phillips, S. Alexander, F. Alvaro, F. Carlesse, B. Fisher, and et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation J Clin Oncol 30 35 2012 Dec 10 4427 4438
34. M.E. Santolaya, M. Villarroel, L.F. Avendano, and J. Cofre Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study Clin Infect Dis 25 1 1997 Jul 92 97
35. J.I. Tokars Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance Clin Infect Dis 39 3 2004 Aug 1 333 341
36. J.A. DesJardin, M.E. Falagas, R. Ruthazer, J. Griffith, D. Wawrose, D. Schenkein, and et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer Ann Intern Med 131 9 1999 Nov 2 641 647
37. G.M. Haeusler, R.S. Phillips, T. Lehrnbecher, K.A. Thursky, L. Sung, and R.A. Ammann Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel Pediatr Blood Cancer 62 3 2015 Mar 483 489
38. M. Hatzistilianou, A. Rekliti, F. Athanassiadou, and D. Catriu Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia Inflamm Res 59 5 2010 May 339 347
39. G. Fleischhack, D. Cipic, J. Juettner, C. Hasan, and U. Bode Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer Intensive Care Med 26 Suppl 2 2000 Mar S202 S211
40. L. Kitanovski, J. Jazbec, S. Hojker, and M. Derganc Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein Support Care Cancer 22 1 2014 Jan 269 277
41. G.M. Haeusler, F. Carlesse, and R.S. Phillips An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer Pediatr Infect Dis J 32 10 2013 Oct e390 e396
42. V. Urbonas, A. Eidukaite, and I. Tamuliene The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia Cytokine 62 1 2013 Apr 34 37
43. A. Mian, D. Becton, R. Saylors, L. James, X. Tang, A. Bhutta, and et al. Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study Pediatr Blood Cancer 59 2 2012 Aug 238 245